Cargando…
Efficacy of ruthenium coordination complex–based Rutherrin in a preclinical rat glioblastoma model
BACKGROUND: Glioblastoma is an aggressive brain cancer in adults with a grave prognosis, aggressive radio and chemotherapy provide only a 15 months median survival. METHODS: We evaluated the tolerability and efficacy of the Ruthenium-based photosensitizer TLD-1433 with apo-Transferrin (Rutherrin) in...
Autores principales: | Munegowda, Manjunatha Akathatti, Fisher, Carl, Molehuis, Daniel, Foltz, Warren, Roufaiel, Mark, Bassan, Jay, Nitz, Mark, Mandel, Arkady, Lilge, Lothar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212850/ https://www.ncbi.nlm.nih.gov/pubmed/32642649 http://dx.doi.org/10.1093/noajnl/vdz006 |
Ejemplares similares
-
Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma
por: Taylor, Jessica T, et al.
Publicado: (2020) -
Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma
por: Brahm, Cyrillo G, et al.
Publicado: (2020) -
The effects of palbociclib in combination with radiation in preclinical models of aggressive meningioma
por: Horbinski, Craig, et al.
Publicado: (2021) -
Preclinical and clinical investigation of intratumoral chemotherapy pharmacokinetics in DIPG using gemcitabine
por: Green, Adam L, et al.
Publicado: (2020) -
Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis
por: Greven, D E A, et al.
Publicado: (2015)